Abstract
Purpose: Tumor angiogenesis is crucial for both the growth of the primary tumor and the development of metastases. Among the factors causing tumor angiogenesis, vascular endothelial growth factor (VEGF) is considered as a leading candidate. We aimed to assess the prognostic significance of VEGF and tumor angiogenesis in head and neck squamous cell carcinoma (HNSCC). Methods: We performed a retrospective study of 69 patients with HNSCC, in order to investigate whether VEGF immunohistochemical expression and tumor angiogenesis correlate with clinicopathological parameters and outcome. Tumor angiogenesis was estimated by determining microvessel density (MVD), and VEGF expression was assessed quantitatively. Results: Vascular endothelial growth factor and MVD correlated statistically significant with the clinical stage, but not with the presence of lymph node metastasis at the time of diagnosis. Tumors located in the oral cavity and larynx more often expressed high VEGF immunostaining compared with tumors located in the lower lip. High VEGF expression was associated with higher clinical stage and worse overall survival in this cohort of patients. Conclusions: Vascular endothelial growth factor expression may have prognostic significance for patients with HNSCC.
Similar content being viewed by others
References
Aebersold DM, Beer KT, Laissue J, Hug S, Kollar A, Greiner RH, Djonov V (2000) Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx. Int J Radiat Oncol Biol Phys 48:17–25
Ahlgren J, Risberg B, Villman K, Bergh J (2002) Angiogenesis in invasive breast carcinoma—a prospective study of tumour heterogeneity. Eur J Cancer 38:64–69
Altman DG, Lausen B, Sauerbrei W, Schumacher M (1994) Dangers of using “optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86:829–835
Artese L, Rubini C, Ferrero G, Fiorini M, Santinelli A, Piatelli A (2001) Microvessel density (MVD) and vascular endothelial growth factor expression (VEGF) in human oral squamous cell carcinoma. Anticancer Res 21:689–696
Breslin JW, Pappas PJ, Cerveira JJ, Hobson RW, Duran WN (2003) VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am J Physiol Heart Circ Physiol 284:92–100
Concato J, Feinstein AR, Holford TR (1993) The risk of determining risk with multivariable models. Ann Intern Med 118:201–210
Dray TG, Hardin NJ, Sofferman RA (1995) Angiogenesis as a prognostic marker in early head and neck cancer. Ann Otol Rhinol Laryngol 104:724–729
Duff SE, Li C, Garland JM, Kumar S (2003) CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17:984–992
Dunphy F, Stack BC Jr, Boyd JH, Dunleavy TL, Kim HJ, Dunphy CH (2002) Microvessel density in advanced head and neck squamous cell carcinoma before and after chemotherapy. Anticancer Res 22:1755–1758
Ellis LM, Liu W, Fan F, Reinmuth N, Shaheen RM, Jung YD, Ahmad S (2001) Role of angiogenesis inhibitors in cancer treatment (Huntingt). Oncology 15:39–46
Ferrara N, Davis-Smith T (1997) The biology of vascular endothelial growth factor. Endocrin Rev 18:4–25
Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM (2000) Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:966–978
Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4–6
Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27–31
Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V, Chiarugi V, Masini E (2001) Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer: implications for tumor angiogenesis and metastasis. Neoplasia 3:53–61
Gallo O, Massini E, Bianchi B, Bruschini L, Paglierani M, Franchi A (2002) Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum Pathol 33:708–714
Gleich LL, Biddinger PW, Pavelic ZP, Gluckman JL (1996) Tumor angiogenesis in T1 oral cavity squamous cell carcinoma: role in predicting tumor aggressiveness. Head Neck 18:343–346
Gupta K, Kshirsagar S, Li W, Gui L, Ramakrishnan S, Gupta P, Law PY, Hebbel RP (1999) VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signalling. Exp Cell Res 247:495–504
Hannen EJ, van der Laak JA, Manni JJ, Freihofer HP, Slootweg PJ, Koole R, de Wilde PC (2002) Computer assisted analysis of the microvasculature in metastasized and nonmetastasized squamous cell carcinomas of the tongue. Head Neck 24:643–650
Homer JJ, Prentice MG, Cawkwell L, Birchall M, Greemman J, Stafford ND (2003) Angiogenesis and expression of vascular endothelial growth factors A and C in squamous cell carcinoma of the piriform fossa. Arch Otolaryngol Head Neck Surg 129:1110–1114
Ikeda N, Adachi M, Taki T, Huang C, Hashida H, Takabayashi A, Sho M, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H, Miyake M (1999) Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 79:1553–1563
Janot F, Klijanienko J, Russo A, Mamet JP, de Braud F, El-Naggar AK, Pignon JP, Luboinski B, Cvitkovic E (1996) Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis. Br J Cancer 73:531–538
Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290–298
Kowalski LP, Medina JE (1998) Nodal metastases: predictive factors. Otolaryngol Clin North Am 31:621–637
Kyzas AP, Stefanou D, Agnantis NJ (2004a) Immunohistochemical expression of vascular endothelial growth factor correlates with positive surgical margins and recurrence in T1 and T2 squamous cell carcinoma (SCC) of the lower lip. Oral Oncol 40:941–947
Kyzas PA, Stefanou D, Agnantis NJ (2005) COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma. Mod Pathol 18:153–160
Lalla RV, Boisoneau DS, Spiro JD, Kreutzer DL (2003) Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 129:882–888
Leedy DA, Trune DR, Kronz JD, Weidner N, Cohen JI (1994) Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous carcinoma of the tongue. Otolaryngol Head Neck Surg 111:417–422
Linder S, Blasjo M, von Rosen A, Parrado C, Falkmer UG, Falkmer S (2001) Pattern of distribution and prognostic value of angiogenesis in pancreatic duct carcinoma: a semiquantitative immunohistochemical study of 45 patients. Pancreas 22:240–247
Maeda T, Matsumura S, Hiramura H, Jikko A, Furukawa S, Ishida T, Fuchihata H (1998) Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its asspciation with tumour progression and p53 gene status. J Clin Pathol 51:771–775
Meert AP, Paesmans M, Martin B, Delmotte P, Berghmans T, Verdebout JM, Lafitte JJ, Mascaux C, Sculier JP (2002) The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 87:694–701
Mineta H, Miura K, Ogino T, Satoru T, Misawa K, Ueda Y (2002) Vascular endothelial growth factor (VEGF) expression correlates with p53 and ki-67 expressions in tongue squamous cell carcinoma. Anticancer Res 22:1039–1044
Moriyama M, Kumagai S, Kawashiri S, Kojima K, Kakihara K, Yamamoto E (1997) Immunohistochemical study of tumor angiogenesis in oral squamous cell carcinoma. Oral Oncol 33:369–374
Neuchrist C, Quint C, Pammer A, Burian M (1999) Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: an immunohistochemical study. Acta Otolaryngol (Stockh) 119:732–738
Neuchrist C, Erovic BM, Handisurya A, Fischer MB, Steiner GE, Hollemann D, Gedlicka C, Saaristo A, Burian M (2003) Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head Neck 25:464–474
Pazouki S, Chisholm DM, Adi MM, Carmichael G, Farquharson M, Ogden GR, Schor SL, Schor AM (1997) The association between tumour progression and vascularity in the oral mucosa. J Pathol 183:39–43
Penfold CN, Partridge M, Rojas R, Langdon JD (1996) The role of angiogenesis in the spread of oral squamous cell carcinoma. Br J Oral Maxillofac Surg 34:37–41
Reinmuth N, Parikh AA, Ahmad SA, Liu W, Stoeltzing O, Fan F, Takeda A, Akagi M, Ellis LM (2003) Biology of angiogenesis in tumors of the gastrointestinal tract. Microsc Res Tech 60:199–207
Riedel F, Gotte K, Schwalab J, Schafer C, Hormann K (2000) Vascular endothelial growth factor correlates with p53 mutations and angiogenesis in squamous cell carcinoma of the head and neck. Acta Otolaryngol 120:105–111
Salven P, Heikkila P, Anttonen A, Kajanti M, Joesuu H (1997) Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Mod Pathol 10:1128–1133
Sawatsubashi M, Yamada T, Fukushima N, Mizokami H, Tokunaga O, Shin T (2000) Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Arch 436:243–248
Schimming R, Marme D (2002) Endoglin (CD105) expression in squamous cell carcinoma of the oral cavity. Head Neck 24:151–156
Shpitzer T, Chaimoff M, Gal R, Stern Y, Feinmesser R, Segal K (1996) Tumor angiogenesis as a prognostic factor in early oral tongue cancer. Arch Otolaryngol Head Neck Surg 122:865–868
Smith BD, Smith GL, Carter D, Sasaki CT, Hafty BG (2000) Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 18:2046–2052
Tae K, El-Naggar A, Yoo E, Feng L, Lee J, Hong WK, Hittelman WN, Shin DM (2000) Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis. Clin Cancer Res 6:2821–2828
Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T (1997) Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 15:826–832
Underiner TL, Ruggeri B, Gingrich DE (2004) Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy. Curr Med Chem 11:731–745
Vermeulen PB, Fox SB, Dirix LY, Colpaert C, Van Marck EA (2002a) Heterogeneity of vascularisation in invasive breast carcinoma. Eur J Cancer 38:1951–1952
Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M (2002b) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38:1564–1579
Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1–8
Williams JK, Carlson GW, Cohen C, Derose PB, Hunter S, Jurkiewicz MJ (1994) Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg 168:373–380
Xiangming C, Hokita S, Natsugoe S, Tanabe G, Baba M, Takao S, Kuroshima K, Aikou T (1998) Angiogenesis as an unfavorable factor related to lymph node metastasis in early gastric cancer. Ann Surg Oncol 5:585–589
Author information
Authors and Affiliations
Corresponding author
Additional information
The manuscript has been read and approved by all the authors. All persons designated as authors have sufficiently participated in the work to take public responsibility for the content of the manuscript and each author believes that the manuscript represents honest work. DS generated the original idea and the protocol was developed by PAK and DS, and commented by AB and NJA. PAK performed the laboratory procedures; PAK and DS evaluated the experimental results and performed the statistical analyses. All authors interpreted the findings. PAK, DS, and AB drafted the final manuscript and NJA revised it critically. Conflicts of interest: None. Funding: None
Rights and permissions
About this article
Cite this article
Kyzas, P.A., Stefanou, D., Batistatou, A. et al. Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol 131, 624–630 (2005). https://doi.org/10.1007/s00432-005-0003-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-005-0003-6